Filing Details

Accession Number:
0001209191-18-034485
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-31 18:59:42
Reporting Period:
2018-05-29
Accepted Time:
2018-05-31 18:59:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607678 Viking Therapeutics Inc. VKTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1438421 W Stephen Webster C/O Viking Therapeutics, Inc.
12340 El Camino Real, Suite 250
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Per Share Acquisiton 2018-05-29 8,000 $5.21 8,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.203 to $5.216, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.